Option Care Health Sets Dec. 15 Vote on $32.05 Cash Takeover by CD&R
Option Care Health filed a definitive merger proxy for a Dec. 15 special meeting where stockholders will vote on its $32.05-per-share cash sale to investment funds managed by Clayton, Dubilier & Rice.
What happened
Option Care Health, Inc. filed a definitive proxy statement with the SEC on November 9, 2026, setting a special meeting of stockholders for December 15, 2026 at 9 a.m. Central Time. The meeting will be held virtually, at www.virtualshareholdermeeting.com/OPCH2026SM.
Stockholders will vote on a proposal to adopt an Agreement and Plan of Merger dated October 5, 2026, among Option Care Health, Onyx Bidco LLC and Onyx Merger Sub, Inc. Parent and Merger Sub were formed by investment funds managed by Clayton, Dubilier & Rice, LLC, according to the filing.
Under the terms described in the proxy, Merger Sub will merge into Option Care Health, which will survive as a wholly owned subsidiary of Parent. Each outstanding share of Option Care Health common stock will be converted into the right to receive $32.05 in cash, without interest, unless the holder perfects statutory appraisal rights under Delaware law.
The board unanimously determined the merger is fair to and in the best interests of the company and stockholders, approved the agreement, and recommends stockholders vote "FOR" the merger proposal, "FOR" the advisory proposal on named executive officer compensation tied to the merger, and "FOR" a proposal to adjourn the meeting if needed to solicit votes.
Stockholders of record as of the close of business on November 3, 2026 are entitled to vote. Adoption of the merger agreement requires the affirmative vote of holders of a majority of the issued and outstanding shares entitled to vote at the meeting.
The company and the price
Option Care Health is based in Bannockburn, Illinois, and is classified in SEC filings under home health care services. The proxy does not describe the company's business in detail.
The stock closed at $31.69 on the session covered by the accompanying price data, up 0.13% from the prior close of $31.65. The $32.05 cash merger consideration is 36 cents, or about 1.1%, above that close.
What this means
A DEFM14A is a definitive merger proxy. "Definitive" means the document is final rather than a draft, and it is the version actually mailed to shareholders. Companies file one when stockholders must vote on a merger or similar transaction, and it serves as the formal disclosure of the deal terms, the board's reasoning, and the mechanics of the vote.
The structure described here is a cash merger: a newly formed acquisition subsidiary, Merger Sub, merges into Option Care Health, and the public company becomes a private subsidiary of Onyx Bidco LLC, an entity formed by CD&R-managed funds. A shareholder's only remaining economic interest is the $32.05 per share, so the vote is essentially a yes-or-no on that price.
Delaware law gives dissenting stockholders appraisal rights. A holder who does not vote in favor and follows the procedures in Section 262 of the Delaware General Corporation Law can ask a Delaware court to determine the "fair value" of their shares, exclusive of any value from the merger itself.
What happens next
The special meeting is scheduled for December 15, 2026. If the merger agreement is adopted by the required majority and the other conditions in the agreement are satisfied, the merger would close and shares would convert into the $32.05 cash payment. The proxy states that stockholders who hold shares in street name must give voting instructions to their bank or broker, because the broker cannot vote on the merger proposal without them. Shares that are not voted count as votes against the merger proposal.
Sources
- DEFM14A filed 2026-11-09
- Daily price history
Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.